Ophthalmologic irrigation solutions and method
a technology for ophthalmologic irrigation and solutions, applied in the direction of anti-noxious agents, drug compositions, peptide/protein ingredients, etc., can solve the problems of reducing the therapeutic efficacy of the agent, not always providing a defined dosage method, etc., to reduce the side effects of ocular therapy, increase the efficacy, and reduce the intraocular pressure
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Examples
example 1
[0095] Exemplary ophthalmologic solutions of the present invention for use during cataract removal surgery are described in Tables 20, 21 and 22. This solution, and the following solutions of Tables 23-25, are provided by way of example only, and are not intended to limit the invention. Anti-inflammatories are believed to be particularly useful in cataract solutions of the invention, to potentially reduce the post-operative incidence of, or hasten resolution of, cystoid macular edema (CME). These exemplary solutions and the other exemplary ophthalmologic irrigation solutions described herein below are provided in terms of the concentration of each agent included in the previously described preferred balanced-salt solution. The solution may suitably be supplied in 500 ml bags, this being the quantity of irrigation solution typically applied during a procedure, by way of non-limiting example.
20TABLE 20 Exemplary Cataract Solution Concentration Class of (Nanomolar): Most Agent Drug The...
example 2
[0098] A similar irrigation solution including multiple agents for effective reduction of inflammation and to provide mydriasis for invasive ophthalmologic surgery, such as a trabeculectomy, is provided in Table 23.
23TABLE 23 Exemplary Trabeculectomy Solution Concentration Class (Nanomolar): Most of Agent Drug Therapeutic Preferred Preferred anti- prednis-10-1,000,000 100-100,000 1,000-10,000 inflam- olone matory anti- flurbi- 10-1,000,000 100-100,000 1,000-10,000 inflam-profen matory IOP red. timolol 10-1,000,000 100-100,000 1,000-10,000 agent mydriatic phenyle- 50-500,000 500-100,000 1,000-10,000 phrine
example 3
[0099] Irrigation solutions suitably used for extensive ophthalmologic surgery or posterior ocular chamber procedures, such as vitrectomy, provide increased analgesia by the addition of a local anesthetic. Such solutions of the present invention including a local anesthetic are provided in Tables 24 and 25.
24TABLE 24 Exemplary Local Anesthetic Ophthalmologic Solution Concentration Class (Nanomolar): Most of Agent Drug Therapeutic Preferred Preferred IOP red. timolol 10-1,000,000 100-100,000 1,000-10,000 agent anti- flurbi- 10-1,000,000 100-100,000 1,000-10,000 inflam- profen matory mydriatic tropica- 10-1,000,000 100-100,000 1,000-10,000 mide analgesic lidocaine 1,000-10,000- 100,000- 100,000,000 10,000,000 1,000,000
[0100]
25TABLE 25 Alternate Exemplary Local Anesthetic Ophthalmologic Solution Concentration Class of (Nanomolar): Most Agent Drug Therapeutic Preferred Preferred IOP red. timolol 10-1,000,000 100-100,000 1,000-10,000 agent anti- flurbi- 10-1,000,000 100-100,000 1,000-10,...
PUM
Property | Measurement | Unit |
---|---|---|
Power | aaaaa | aaaaa |
Molar density | aaaaa | aaaaa |
Molar density | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com